Open Orphan name change to hVIVO effective 26th October 2022

Clinical trials are essential for advancing medicine, enhancing drug discovery, and improving patient safety. There are two main types of clinical trials: observational and interventional. Understanding these types helps researchers conduct thorough, safe, effective, and compliant

hVIVO’s CEO addressed the Canary Wharf group, discussing their world-leading title in human challenge trials and the company’s relocation to Canary Wharf. Yamin ‘Mo’ Khan emphasised hVIVO’s fit-for-purpose facility, featuring a 50-bed quarantine unit, and highlighted

Hvivo, a Dublin and London-listed pharmaceutical services company, reported a record revenue for the first half of the year, continuing its momentum in the market. Specialising in testing infectious and respiratory disease products, Hvivo announced that

Clinical trials are a critical component of medical research, involving the testing of pharmaceutical drugs, medical devices, or other treatments on human participants to evaluate their efficacy and safety. These trials play a crucial role in

The recent rise of the “tripledemic” – the simultaneous spread of the influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older adults and those with chronic conditions or compromised

A recent study published in the journal Nature analyzed early cellular response dynamics to SARS-CoV-2 in seronegative individuals using single-cell multi-omics profiling, identifying key cellular states and immune responses associated with different infection outcomes. COVID-19, caused

Fifty years ago this month, India experienced its final seasonal smallpox epidemic. Nearly 200,000 infections were recorded, resulting in over 30,000 deaths. By May 1975, the last case of smallpox in India was diagnosed, and in

A travellers’ vaccine is administered to individuals from non-endemic regions before they travel to areas where certain diseases are prevalent. These vaccines are crucial for travel medicine, protecting travellers and preventing the importation of vaccine-preventable diseases

Infectious diseases account for 7% of deaths in the UK and cost the economy £30 billion annually, significantly burdening the NHS and affecting productivity and wellbeing. Human challenge trials (HCTs), where volunteers are deliberately infected with

In June 2024, hVIVO announced a £2.5 million contract with a mid-sized pharmaceutical company to launch an Omicron characterisation study. This study aims to determine a dose of hVIVO’s Omicron BA.5 challenge agent that establishes a

Shares in the London and Dublin-listed life sciences firm hVivo saw a rise on Monday following the announcement of its inaugural Covid vaccine-related contract. Formerly known as Open Orphan, the company disclosed a £2.5 million (€2.9

Hvivo, a pharmaceutical services company listed on the Dublin and London stock exchanges, has secured a £2.5 million (€2.9m) contract with a mid-sized pharmaceutical company to start a Covid-19 characterisation study. In 2023, Hvivo successfully completed

Participating in a clinical trial can be both exciting and confusing, especially when considering the potential health impacts. Clinical trials are essential for determining the efficacy and safety of new treatments. Governing bodies oversee these trials,

People who haven’t had the opportunity to participate in a clinical trial often wonder about eligibility criteria. Each trial has its own goals and purposes, so the inclusion criteria vary. Many trials require participants with specific

Clinical trials play a vital role in the discovery, testing, and eventual marketing of new drugs. Over a million individuals participated in clinical trials during 2022/23, involving more than 6,000 studies. Understanding eligibility criteria for clinical